Literature DB >> 29293883

Down-regulation of CASK in glucotoxicity-induced insulin dysfunction in pancreatic β cells.

Yao Wang1, Nana Hao2, Haiyan Lin3, Tianyuan Wang1, Jinyang Xie1, Yuexing Yuan1.   

Abstract

High-glucose level exerts deleterious effects on pancreatic β cells, but the mechanisms remain unclear. Calcium/calmodulin-dependent serine protein kinase (CASK) plays a vital role in neural development and release of neurotransmitters, and probably plays a role in the anchoring of insulin on pancreatic β cell membrane. Hypoxia-inducible factor 1α (HIF1α) is involved in β-cell dysfunction. The aim of this study was to provide some basic evidence that CASK could be involved in glucotoxicity-induced insulin secretion dysfunction mediated by HIF1α in INS-1E cells. CASK overexpression plasmid, HIF1α agonist (CoCl2), and HIF1α selective inhibitor (KC7F2) were used. The results showed that chronic stimulation with high glucose could induce insulin secretion dysfunction in INS-1E β cells. Overexpression of CASK partially reversed the effects of high glucose on insulin secretion. CoCl2 reduced the expression of CASK, but KC7F2 reversed the glucotoxicity-induced CASK level reduction. These results suggested that glucotoxicity-induced insulin secretion defects in INS-1E cells could be mediated by HIF1α via the down-regulation of CASK.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29293883     DOI: 10.1093/abbs/gmx139

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  2 in total

1.  Molecular regulation of lifespan extension in fertile ant workers.

Authors:  Matteo Antoine Negroni; Maide Nesibe Macit; Marah Stoldt; Barbara Feldmeyer; Susanne Foitzik
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2021-03-08       Impact factor: 6.237

2.  Cask methylation involved in the injury of insulin secretion function caused by interleukin1-β.

Authors:  Tian-Yuan Wang; Xing-Jing Liu; Jin-Yang Xie; Qing-Zhao Yuan; Yao Wang
Journal:  J Cell Mol Med       Date:  2020-11-14       Impact factor: 5.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.